Delivered-To: tjphuhs@gmail.com Received: by 2002:adf:f706:0:b0:439:567a:e7b2 with SMTP id r6csp419414wrp; Wed, 18 Feb 2026 15:06:21 -0800 (PST) X-Received: by 2002:a05:620a:29cf:b0:8ca:123e:8194 with SMTP id af79cd13be357-8cb74043603mr440778385a.33.1771455981486; Wed, 18 Feb 2026 15:06:21 -0800 (PST) ARC-Seal: i=1; a=rsa-sha256; t=1771455981; cv=none; d=google.com; s=arc-20240605; b=jwQXpjVajF93Bwl5pB6Mi3IC25SnlzCd3d2JNziXJGtY1w0z5OumTSa3P8oPMpH+Ul ZCY/UFL/LilqhWwGWbzdtbbrj/7raKE3Ot96JNwBGjSriH0w6ww6zjHE9uIDc4IwsodB h3EHX1maLVSmCQNCvLZl0Vj2P7bV/F2fPD9MIt2bd45sk/XVmOUSf++Tf7PO7GGZYx9b FHpnYNK3bpTS2rURgdKSB6AFCjNjbLKU0pxfuRWV6hy7ayl3vnw2NpeuJu5HroYJ/JIz hFYPzY961WLVKK7rLQ5KymDh8dWW3cYFP6xTDlQU8EshmMdLFUQsM3Y9hv7a4l2Trm/e Lnzg== ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20240605; h=message-id:date:mime-version:sid:subject:reply-to :list-unsubscribe-post:list-unsubscribe:from:feedback-id:to :dkim-signature:dkim-signature; bh=hSWBG+lgbrnjGS50Ug02ZpJmy1c1nQQyO68KTWNBtGg=; fh=Hcu5VqhndQNvtVhwbc8tr7JrSOSQJms/+lG2L+E9gBs=; b=Ke0/jI6JYH+aRZSZXjtJsZ5d7ZnDxo5uwcX4xGgq1NhVdTOT8qQ3eNSS2LuX9dmQ0O /ePgvzHCGTXCfZgmmKkYXh3I1LLlKFFcRUghG1J1/Vg8iZVjwN4FM975tPcwO3dDL5vP XzQNJc1bNFlPI+UHwR/moCjp2MeGtqjAZcKl7zsVarF0BAJwQQV+8xa8pjeMitWh/N92 Mlrvypa84QPkMo6OPlAysVKiJHvE/D2tsXFU+FRY34AFAyt8Bp8mT94bJb5yB4QtN5/j Bz/lfAW6p3u8c2n+S3ndNoNL14/ISa2uHeAUGBqjJHBEErM+Ng8obOUZgTjeVhrh0LQP 9jwQ==; dara=google.com ARC-Authentication-Results: i=1; mx.google.com; dkim=pass header.i=@bhmta.beehiiv.com header.s=bh header.b="DAdf62N/"; dkim=pass header.i=@mail.beehiiv.com header.s=bh header.b=q4lHqQT9; spf=pass (google.com: domain of bounces+tjphuhs=gmail.com@bh.mail.beehiiv.com designates 69.67.186.5 as permitted sender) smtp.mailfrom="bounces+tjphuhs=gmail.com@bh.mail.beehiiv.com"; dmarc=pass (p=REJECT sp=REJECT dis=NONE) header.from=beehiiv.com Return-Path: Received: from bh186-5.smtp-out.beehiivmail.net (bh186-5.smtp-out.beehiivmail.net. [69.67.186.5]) by mx.google.com with ESMTPS id 6a1803df08f44-8971cda2c45si227039646d6.254.2026.02.18.15.06.21 for (version=TLS1_3 cipher=TLS_AES_256_GCM_SHA384 bits=256/256); Wed, 18 Feb 2026 15:06:21 -0800 (PST) Received-SPF: pass (google.com: domain of bounces+tjphuhs=gmail.com@bh.mail.beehiiv.com designates 69.67.186.5 as permitted sender) client-ip=69.67.186.5; Authentication-Results: mx.google.com; dkim=pass header.i=@bhmta.beehiiv.com header.s=bh header.b="DAdf62N/"; dkim=pass header.i=@mail.beehiiv.com header.s=bh header.b=q4lHqQT9; spf=pass (google.com: domain of bounces+tjphuhs=gmail.com@bh.mail.beehiiv.com designates 69.67.186.5 as permitted sender) smtp.mailfrom="bounces+tjphuhs=gmail.com@bh.mail.beehiiv.com"; dmarc=pass (p=REJECT sp=REJECT dis=NONE) header.from=beehiiv.com X-BmtaRef: eyJfQF8iOiJcXF8vIiwicmVjaXBpZW50IjoidGpwaHVoc0BnbWFpbC5jb20iLCJ4X2xpc3RfaWQiOiJmZDQxNjMwZS1lOTFmLTQ2ZDktYTI3NC1iNzQwZGFiNzU2ZDIiLCJ4X3N1YnNjcmliZXJfaWQiOiI5YzQwZDYzOS02ZTFkLTQyOTItYTlkNy0wZTRjYmJiNWQ1ZGIifQ== DKIM-Signature: v=1; a=rsa-sha256; d=bhmta.beehiiv.com; s=bh; c=relaxed/relaxed; bh=hSWBG+lgbrnjGS50Ug02ZpJmy1c1nQQyO68KTWNBtGg=; h=from:subject:mime-version:content-type:content-transfer-encoding: list-unsubcribe:feedback-id:list-unsubscribe-post:reply-to:to:cc: content-type:feedback-id:from:subject:to; t=1771455980; b=DAdf62N/5C3KKGhXgNxSOk2jhNAqvidrAUxYPzqM6fyW9/ChtRhALxBXH/WYuiuoF9hd9ZVKb DBiBgpg0qpXj+Vk2UZdVG79FJ3tqjUpjerGJjIeE+Fm0aGIE1PEg1h7o029YqgVUkInCjfzLN7S 39BIZxWsmqe7qsg6UbBj0wanVBEYziflWRtWetY+/duoYvWKKzjn76iw0MQaNjA9Y7lWdGMK8TV pMat6MTFQd0cxLFJa6OUV6AemrIb2IQo894pM3apCocU0gdtsIFeeTRzwfaU3M1Fc0r7s81ZfHY ts+59wc0rzGWWXWEiqF7W1bLzTxsQNyZL0yuOOLWEgsA==; DKIM-Signature: v=1; a=rsa-sha256; d=mail.beehiiv.com; s=bh; c=relaxed/relaxed; bh=hSWBG+lgbrnjGS50Ug02ZpJmy1c1nQQyO68KTWNBtGg=; h=from:subject:mime-version:content-type:content-transfer-encoding: list-unsubcribe:feedback-id:list-unsubscribe-post:reply-to:to:cc: content-type:feedback-id:from:subject:to; t=1771455980; b=q4lHqQT9TTcE2zHzJCPKA3gSyCDwippB+bYEdL7onzYhseQaxvd+zslgPUzXWMw8ScIP4TD5c 8t4HjyC5h67NReJuTyHtR8+SQQqr+XzXgwGl2C7AclW01BfSJnbHUaUGTsS/+7+MHa/Cno5/5Tz M4nj141C/IQbkwZ1oDI2SK7Ur0I3a93k4uOHSzrqzMfQRdNXRCoRd2OOo2YMSrjSI72ziXqMMn3 eP/MLFj75EfeoHWrNxFXTO0DuEcq4gtdiEV8iJjJkP/tZVvBpIFPcBCIQi+ckS54jdls5vIaXb0 ROWZuYKXAxOf9VjBh4Vsq91Hi7C0NzGKPrm5IXdiuIpA==; Received: from mail.beehiiv.com by bhmta(mta12) with HTTP id <6ff7c45b0d1e11f1a9130ea8fc9efb25> for ; Wed, 18 Feb 2026 23:06:20 +0000 Content-Type: multipart/alternative; boundary="mmDFGwsLQkuOZ7TpD7ugjw" To: "tjphuhs@gmail.com" Feedback-ID: 7aaff993-b3d3-44be-b648-4447f18d7965:newsletter:fd41630e-e91f-46d9-a274-b740dab756d2:c8f61fda6a60803 From: Hunter Williams List-Unsubscribe: , List-Unsubscribe-Post: List-Unsubscribe=One-Click Reply-To: =?utf-8?Q?Hunter=27s_Health_Hacks?= Subject: Thymosin Alpha-1 For Depression? X-Batch-Id: e1264c2a-0f9a-4057-ad77-2a526498e88d X-Subscriber-ID: 9c40d639-6e1d-4292-a9d7-0e4cbbb5d5db sId: fd41630e-e91f-46d9-a274-b740dab756d2 x-beehiiv-ids: {"account_name":"https://huntershealthhacks.beehiiv.com/","campaign_id":"7aaff993-b3d3-44be-b648-4447f18d7965","category":"newsletter","email_generated_at":1771455978,"user_id":"fd41630e-e91f-46d9-a274-b740dab756d2"} x-beehiiv-type: newsletter x-list-id: fd41630e-e91f-46d9-a274-b740dab756d2 x-list-owner: x-newsletter: https://huntershealthhacks.beehiiv.com/p/thymosin-alpha-1-for-depression x-newsletter-id: https://huntershealthhacks.beehiiv.com/ x-newsletter-signup: https://huntershealthhacks.beehiiv.com/subscribe Mime-Version: 1.0 Date: Wed, 18 Feb 2026 23:06:20 +0000 Message-ID: <20260218.230620.b334ace8@mta12> --mmDFGwsLQkuOZ7TpD7ugjw Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: quoted-printable Happy Wednesday! =0A=0AI was digging through recent literature this week an= d came across a [2025 human study](https://pmc.ncbi.nlm.nih.gov/articles/PM= C11762651/) that immediately caught my attention. ([Click here to read it](= https://pmc.ncbi.nlm.nih.gov/articles/PMC11762651/))=0A=0AIt looked at thym= osin alpha-1 in patients with common variable immune deficiency who were al= so dealing with depression.=0A=0AAnd what it showed was fascinating. Improv= ements in immune markers were accompanied by improvements in depressive sym= ptoms.=0A=0AFor years, I have been saying that if you do not address immune= dysfunction, you are often missing the deeper layer of what is driving moo= d instability, fatigue, lack of motivation, and brain fog.=0A=0AThis study = reinforces something I have believed for a long time. Thymosin alpha-1 may = be more than an =E2=80=9Cimmune peptide.=E2=80=9D It may be a neuro-immune = modulator.=0A=0AAnd that changes how we think about it.=0A=0A=E2=80=9CFYI,= =C2=A0[BioLongevity Labs=C2=A0](https://biolongevitylabs.com/)is running a = storewide sale where everything is 30% off (including[ thymosin alpha-1](ht= tps://biolongevitylabs.com/product/thymosin-alpha-1-10mg)). You can use cod= e HUNTERW to get an additional 15% off.=E2=80=9C =E2=80=94 =0A=0A=E2=80=94= =E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2= =80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80= =94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94= =E2=80=94=0A=0A**We Usually Think About TA-1 Only When Someone Is Sick**=0A= =0AMost people associate thymosin alpha-1 with being sick.=0A=0AViral infec= tions. Immune suppression. Cancer adjunct protocols. Sepsis. Chronic infect= ions. Immune rebuilding after damage.=0A=0AIt has become the peptide you pu= ll out when someone is clearly ill.=0A=0AThat thinking isn=E2=80=99t wrong,= but there=E2=80=99s so much more to what it=E2=80=99s doing in the body. = =0A=0AIt is an immune regulator. It supports T-cell maturation, balances Th= 1 and Th2 responses, and improves immune surveillance. It helps the body re= calibrate.=0A=0AThat recalibration is what is interesting.=0A=0ABecause man= y people who struggle with depression do not present as =E2=80=9Csick.=E2= =80=9D They present as tired, inflamed, unmotivated, flat, anxious, or disc= onnected. Underneath that presentation, however, there is often chronic low= -grade immune activation or immune dysregulation.=0A=0AIf that is the case,= the tool we thought was only for infection may actually be addressing some= thing much deeper.=0A=0A=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80= =94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94= =E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2= =80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=0A=0A**Depression**=0A=0AWe have= been conditioned to think of depression as a serotonin deficiency.=0A=0AHo= wever, there is now an entire body of literature around inflammatory depres= sion. Elevated cytokines. Microglial activation. Altered kynurenine pathway= metabolism. Disrupted T-cell signaling.=0A=0AInflammation alters neurotran= smitter production. It alters dopamine signaling. It alters motivation and = reward circuitry. It changes how the brain interprets stress.=0A=0AWhen imm= une cells are chronically activated, they produce cytokines that can cross = the blood brain barrier. =0A=0AThose cytokines influence the hypothalamic-p= ituitary-adrenal axis. They shift tryptophan metabolism away from serotonin= production toward neurotoxic metabolites.=0A=0AYou can throw SSRIs at that= system and sometimes blunt symptoms. But you have not addressed why the im= mune system is misfiring in the first place.=0A=0AThis is where thymosin al= pha-1 becomes extremely interesting.=0A=0A=E2=80=94=E2=80=94=E2=80=94=E2=80= =94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94= =E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2= =80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=0A=0A**What Th= is 2025 Study Suggests**=0A=0AIn this recent human study involving patients= with common variable immune deficiency who were also experiencing depressi= on, researchers administered thymosin alpha-1 and tracked both immune param= eters and mood outcomes.=0A=0AThe study was small and open-label, but the s= ignal was clear enough to warrant attention.=0A=0APatients demonstrated imp= rovements in immune markers alongside reductions in depressive symptoms.=0A= =0ANow, was TA-1 directly acting as an antidepressant? Probably not in the = traditional sense.=0A=0AMore likely, it was restoring immune balance. When = the immune system recalibrates, inflammatory signaling drops. =0A=0AWhen in= flammatory signaling drops, the brain environment improves. When the brain = environment improves, mood stabilizes.=0A=0AThat is a root cause interventi= on.=0A=0A=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2= =80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80= =94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94= =E2=80=94=E2=80=94=E2=80=94=0A=0A**Why TA-1 May Help Address the Root Cause= of Depression**=0A=0ALet us connect the dots.=0A=0ATA-1 enhances T-cell di= fferentiation and function. It promotes immune surveillance while reducing = pathological immune activation. It modulates cytokine profiles. It supports= immune homeostasis.=0A=0AIf depression is partially driven by chronic immu= ne dysregulation, then restoring immune balance may reduce neuroinflammatio= n.=0A=0ALess neuroinflammation means improved dopamine signaling. Improved = mitochondrial efficiency. Better stress tolerance. Clearer cognition. More = stable mood.=0A=0APeople who start TA-1 for immune reasons often report sec= ondary benefits. Improved resilience. Clearer thinking. A subtle lift in mo= od. Less emotional volatility.=0A=0AAnd that stabilization may be the nervo= us system finally exiting an inflammatory state.=0A=0A=E2=80=94=E2=80=94=E2= =80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80= =94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94= =E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=0A= =0A**Dosage for Depression**=0A=0ABased on both the literature and my clini= cal experience, here is how I like to approach thymosin alpha-1 for immune = recalibration and mood support.=0A=0A* 1 mg per day=0A=0A* 5 days on=0A=0A*= 2 days off=0A=0A* For 8 weeks=0A=0AThat provides the immune system with su= fficient consistent signaling to shift patterns without inducing overactiva= tion.=0A=0AEight weeks allows for meaningful immune remodeling. Remember, T= -cell dynamics and cytokine environments do not change overnight.=0A=0AI pr= efer subcutaneous administration. =0A=0AAfter eight weeks, reassess.=0A=0AS= ome individuals may not need continuous use. Others with deeper immune dysf= unction may benefit from periodic cycles.=0A=0A=E2=80=94=E2=80=94=E2=80=94= =E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2= =80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80= =94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=0A=0A**W= hy This Is Different Than Traditional Depression Approaches**=0A=0AMost con= ventional depression treatments attempt to manipulate neurotransmitters dow= nstream.=0A=0AIncrease serotonin. Block reuptake. Increase norepinephrine. = Increase dopamine.=0A=0AThat is like adjusting the thermostat while the fur= nace is malfunctioning.=0A=0AIf the immune system is chronically activated,= cytokines are elevated, and microglia are primed, then neurotransmitter ma= nipulation is superficial.=0A=0ATA-1 works upstream.=0A=0AIt addresses immu= ne tone.=0A=0AAnd immune tone influences brain tone.=0A=0AThis is why I get= excited about peptides like this. They operate at the systems level, regul= ating and nudging the body back toward equilibrium.=0A=0A=E2=80=94=E2=80=94= =E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2= =80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80= =94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94= =0A=0A**Important Caveats**=0A=0AThis was a small study. It was not a large= randomized placebo-controlled trial for major depressive disorder in other= wise healthy individuals.=0A=0AWe need more data.=0A=0AWe need larger cohor= ts.=0A=0AWe need biomarker stratification to identify which subtype of depr= ession responds best.=0A=0ABut early signals matter.=0A=0AEspecially when t= hey align with what we already understand about inflammation, immunity, and= brain function.=0A=0ATA-1 is not a magic antidepressant. It is not for eve= ry case of depression. If someone=E2=80=99s depression is primarily situati= onal or trauma-based, immune modulation alone will not solve it.=0A=0ABut f= or the subset of individuals with immune dysfunction, chronic inflammation,= autoimmunity, or recurrent infections, this could be a meaningful lever.= =0A=0A=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80= =94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94= =E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2= =80=94=E2=80=94=E2=80=94=0A=0A**Final Thoughts**=0A=0AFor years, I have tau= ght that the immune system cannot be separated from the nervous system.=0A= =0AThey are in constant dialogue.=0A=0AThe fact that we are now seeing huma= n data showing immune and mood improvements should not surprise us.=0A=0AIt= should validate the direction of inquiry.=0A=0AThymosin alpha-1 is more th= an a =E2=80=9Cwhen you are sick=E2=80=9D peptide.=0A=0AIt is a regulator.= =0A=0AIf you are dealing with depression that has not responded fully to co= nventional approaches, especially in the context of autoimmune issues or im= mune compromise, this is worth discussing with a knowledgeable provider.=0A= =0AAddress the immune system. Support the brain by stabilizing the environm= ent around it.=0A=0AHopefully, this approach will be where the future of me= ntal health is headed! =0A=0ABest,=0A=0AHunter Williams=0A=0A=0A=E2=80=94= =E2=80=94=E2=80=94=0A=0AYou are reading a plain text version of this post. = For the best experience, copy and paste this link in your browser to view t= he post online:=0Ahttps://huntershealthhacks.beehiiv.com/p/thymosin-alpha-1= -for-depression --mmDFGwsLQkuOZ7TpD7ugjw Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable Thymosin Alpha-1 For Depression?
New study just released=  ‌ ‌ ‌ ‌ ‌ = 204; ‌ ‌ ‌ ‌ ‌ = ‌ ‌ ‌ ‌ ‌ ‌= 60;‌ ‌ ‌ ‌ ‌ ‌=  ‌ ‌ ‌ ‌ ‌ R= 04; ‌ ‌ ‌ ‌ ‌ &= #8204; ‌ ‌ ‌ ‌ ‌= 0;‌ ‌ ‌ ‌ ‌ ‌&= #160;‌ ‌ ‌ ‌ ‌ ̴= 4; ‌ ‌ ‌ ‌ ‌ &#= 8204; ‌ ‌ ‌ ‌ ‌ = ;‌ ‌ ‌ ‌ ‌ ‌&#= 160;‌ ‌ ‌ ‌ ‌ ‌= ; ‌ ‌ ‌ ‌ ‌ = 204; ‌ ‌ ‌ ‌ ‌ = ‌ ‌ ‌ ‌ ‌ ‌= 60;‌ ‌ ‌ ‌ ‌ ‌=  ‌ ‌ ‌ ‌ ‌ R= 04; ‌ ‌ ‌ ‌ ‌ &= #8204; ‌ ‌ ‌ ‌ ‌= 0;‌ ‌ ‌ ‌ ‌ ‌&= #160;‌ ‌ ‌ ‌ ‌ ̴= 4; ‌ ‌ ‌ ‌ ‌ &#= 8204; ‌ ‌ ‌ ‌ ‌ = ;‌ ‌ ‌ ‌ ‌ ‌&#= 160;‌ ‌ ‌ ‌ ‌ ‌= ; ‌ ‌ ‌ ‌ ‌ = 204; ‌ ‌ ‌ ‌ ‌ = ‌ ‌ ‌ ‌ ‌ ‌= 60;‌ ‌ ‌ ‌ ‌ ‌=  ‌ ‌ ‌ ‌ ‌ R= 04; ‌ ‌ ‌ ‌ ‌ &= #8204; ‌ ‌ ‌ ‌ ‌= 0;‌ ‌ ‌ ‌ ‌ ‌&= #160;‌ ‌ ‌ ‌

February 18, 2026   |   Read Online

Thymosin Alpha-1 For D= epression?

New study just released

3D"share
 <= /tr>
3D"share
 
=3D"share
= 		 
3D"share
3D""
<= td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;wo= rd-break:break-word;">

It has become the peptide you pull out when someone = is clearly ill.

In this recent human study involving patients with comm= on variable immune deficiency who were also experiencing depression, resear= chers administered thymosin alpha-1 and tracked both immune parameters and = mood outcomes.

=
Ha= ppy Wednesday!

I was diggin= g through recent literature this week and came across a 2025 human study that immediately caught = my attention. (Click here to read it)

It looke= d at thymosin alpha-1 in patients with common variable immune deficiency wh= o were also dealing with depression.

And what it showed was fascinating. Improvements in immune markers= were accompanied by improvements in depressive symptoms.

For years, I have been saying that if you do = not address immune dysfunction, you are often missing the deeper layer of w= hat is driving mood instability, fatigue, lack of motivation, and brain fog= .

This study reinforces some= thing I have believed for a long time. Thymosin alpha-1 may be more than an= =E2=80=9Cimmune peptide.=E2=80=9D It may be a neuro-immune modulator.

And that changes how we think ab= out it.

FYI,=C2=A0BioLongevity Labs= =C2=A0is running a stor= ewide sale where everything is 30% off (including thymosin alpha-1). You can use code HUNTER= W to get an additional 15% off.

 

We Usually Think About TA-1 Only When Someone Is Sick<= /span>

Most people associate thymos= in alpha-1 with being sick.

Viral infections. Immune suppression. Cancer adjunct protocols. Sepsis. Ch= ronic infections. Immune rebuilding after damage.

That thinkin= g isn=E2=80=99t wrong, but there=E2=80=99s so much more to what it=E2=80=99= s doing in the body.

It is = an immune regulator. It supports T-cell maturation, balances Th1 and Th2 re= sponses, and improves immune surveillance. It helps the body recalibrate.

That recalibration is what is= interesting.

Because many p= eople who struggle with depression do not present as =E2=80=9Csick.=E2=80= =9D They present as tired, inflamed, unmotivated, flat, anxious, or disconn= ected. Underneath that presentation, however, there is often chronic low-gr= ade immune activation or immune dysregulation.

If that is the case, the tool we thought was only for in= fection may actually be addressing something much deeper.

 

Depression

We have= been conditioned to think of depression as a serotonin deficiency.<= /p>

However, there is now an entire bod= y of literature around inflammatory depression. Elevated cytokines. Microgl= ial activation. Altered kynurenine pathway metabolism. Disrupted T-cell sig= naling.

Inflammation alters = neurotransmitter production. It alters dopamine signaling. It alters motiva= tion and reward circuitry. It changes how the brain interprets stress.

When immune cells are chronicall= y activated, they produce cytokines that can cross the blood brain barrier.=

Those cytokines influence = the hypothalamic-pituitary-adrenal axis. They shift tryptophan metabolism a= way from serotonin production toward neurotoxic metabolites.

<= span style=3D"font-size:1.5rem;">You can throw SSRIs at that system and som= etimes blunt symptoms. But you have not addressed why the immune system is = misfiring in the first place.

This is where thymosin alpha-1 becomes extremely interesting.

<= /td>
 

What This 2025 Study Suggests

The study was= small and open-label, but the signal was clear enough to warrant attention= .

Patients demonstrated impr= ovements in immune markers alongside reductions in depressive symptoms.

Now, was TA-1 directly acting a= s an antidepressant? Probably not in the traditional sense.

More likely, it was restoring immune balanc= e. When the immune system recalibrates, inflammatory signaling drops.

When inflammatory signaling drop= s, the brain environment improves. When the brain environment improves, moo= d stabilizes.

That is a root= cause intervention.

But early signals matter.

=
 

Why TA-1 May Help Address the = Root Cause of Depression

Let us connect the dots.

TA= -1 enhances T-cell differentiation and function. It promotes immune surveil= lance while reducing pathological immune activation. It modulates cytokine = profiles. It supports immune homeostasis.

If depression is partially driven by chronic immune dysregula= tion, then restoring immune balance may reduce neuroinflammation.

Less neuroinflammation means improved= dopamine signaling. Improved mitochondrial efficiency. Better stress toler= ance. Clearer cognition. More stable mood.

People who start TA-1 for immune reasons often report second= ary benefits. Improved resilience. Clearer thinking. A subtle lift in mood.= Less emotional volatility.

And that stabilization may be the nervous system finally exiting an inflam= matory state.

=
 

= Dosage for Depression

Based on both the literature and my clin= ical experience, here is how I like to approach thymosin alpha-1 for immune= recalibration and mood support.

  • 1 mg per day

  • 5 days on

  • 2 days off

    • For 8 weeks

That provides the immune system with sufficient consistent signaling to s= hift patterns without inducing overactivation.

Eight weeks allows for meaningful immune remodeling. Rem= ember, T-cell dynamics and cytokine environments do not change overnight.

I prefer subcutaneous adminis= tration.

After eight weeks,= reassess.

Some individuals = may not need continuous use. Others with deeper immune dysfunction may bene= fit from periodic cycles.

 

Why This Is Different Than= Traditional Depression Approaches

Most conventional depression treatments attempt to manipulate ne= urotransmitters downstream.

Increase serotonin. Block reuptake. Increase norepinephrine. Increase dopa= mine.

That is like adjusting= the thermostat while the furnace is malfunctioning.

If the immune system is chronically activated, cyt= okines are elevated, and microglia are primed, then neurotransmitter manipu= lation is superficial.

TA-1 = works upstream.

It addresses= immune tone.

And immune ton= e influences brain tone.

Thi= s is why I get excited about peptides like this. They operate at the system= s level, regulating and nudging the body back toward equilibrium.

 

Important Caveats

This was a small study. It was not a large randomized placebo-contr= olled trial for major depressive disorder in otherwise healthy individuals.=

We need more data.

We need larger cohorts.

We need biomarker stratification to iden= tify which subtype of depression responds best.

Especially when they align with what we already understan= d about inflammation, immunity, and brain function.

TA-1 is not a magic antidepressant. It is not for e= very case of depression. If someone=E2=80=99s depression is primarily situa= tional or trauma-based, immune modulation alone will not solve it.

But for the subset of individuals wi= th immune dysfunction, chronic inflammation, autoimmunity, or recurrent inf= ections, this could be a meaningful lever.

=  

Final Tho= ughts

For years, I have = taught that the immune system cannot be separated from the nervous system.<= /span>

They are in constant dialogu= e.

The fact that we are now = seeing human data showing immune and mood improvements should not surprise = us.

It should validate the d= irection of inquiry.

Thymosi= n alpha-1 is more than a =E2=80=9Cwhen you are sick=E2=80=9D peptide.

It is a regulator.

<= span style=3D"font-size:1.5rem;">If you are dealing with depression that ha= s not responded fully to conventional approaches, especially in the context= of autoimmune issues or immune compromise, this is worth discussing with a= knowledgeable provider.

Add= ress the immune system. Support the brain by stabilizing the environment ar= ound it.

Hopefully, this app= roach will be where the future of mental health is headed!

Best,

Hunter Williams

=
3D"ig"3D"yt"
3D""
<= h2 style=3D"color:#2A2A2A;font-weight:normal;mso-line-height-alt:150.0%;"><= span style=3D"font-size:1.5rem;">Want more? Here=E2=80=99s how you can work= with me:

=F0=9F=91=89Join my private coaching group, The AXION Collective= :

=F0=9F=91=89Try Zeroats, the world=E2=80= =99s first sugar-free, naturally flavored oatmeal:

= =F0=9F=91=89Get the Peptide Cheat Sheet:

=F0= =9F=91=89All my daily essentials on Amazon

=

=F0= =9F=91=89Get discounts on your favorite peptides and research chemicals:

=F0=9F=91= =8910% off the BEST workout supplements from Unmatched Supps (pre-workout, = whey protein, creatine, EAAs, electrolytes - use code HUNTERW at checkout):=

=F0=9F=91=89Submit A Video Topic For My Next YouTube Video:

=

Upda= te your email preferences or unsubscribe here

© 2026 Hunter's Health Hacks

228 Park Ave S, #29976, New= York, New York 10003, United States

=
3D"beehiivPowered by beehiiv
Terms of Service
--mmDFGwsLQkuOZ7TpD7ugjw--